Ajanta Pharma Promoter Group Entity Revises Share Pledge Disclosures
Ajanta Pharma Ltd 路 Encumbered Shares - Invocation / Release 路 17 Nov 2026, 3:48 pm
Ajanta Pharma Promoter Group Entity Revises Share Pledge Disclosures Aayush Agrawal Trust, part of Ajanta Pharma's promoter group holding 11.29% equity, submitted revised SEBI SAST disclosures on 16th Nov'26 to explicitly identify lenders and trustees holding pledged shares. Pledges were created over 4,60,000 shares (0.37% of capital) on 28th Sep'26 and 30,000 shares (0.02%) on 15th Oct'26 in favour of CTL Trusteeship Limited on behalf of 360 ONE Income Opportunities Funds and 360 ONE Prime to raise acquisition funds. Post-transactions, the trust's total encumbered shares rose to 1,21,32,386 shares, representing 9.71% of total share capital.
Original exchange filing (PDF)
More announcements from Ajanta Pharma Ltd
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 09, 2026 for Aayush Agrawal, .... 路 09 Nov 2026
- Pls find enclosed Earnings Call Written Transcript 路 04 Nov 2026
- Pls find enclosed Audio recording of Earnings Call 路 30 Oct 2026
- Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 30 Oct 2026
- Pls find enclosed results for the quarter ended 30.09.2026. 路 30 Oct 2026
- Pls find enclosed Financial Results for the quarter ended 30.09.2026. 路 30 Oct 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 19, 2026 for Aayush Agrawal, trustee .... 路 21 Oct 2026
- Pls find enclosed Earnings Conference Call Intimation. 路 30 Oct 2026
